Viewing nowCombinationTelmtwin Tablet 40/5 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Samsung Pharmaceutical Co., Ltd.

MFDS item code 201701409 · Approved 2017.03.23 · Insurance code 642306940
Treatment of essential hypertension not controlled with monotherapy
This medicine is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with amlodipine or telmisartan, thereby reducing the risk of cardiovascular disease.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: Although the usual amlodipine dosage is recommended for older adults, caution should be exercised when increasing the dose (see section ‘3. Patients requiring cautious administration’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medicine may cause serious harm to the fetus, particularly during the second and third trimesters of pregnancy, so pregnant women or those who may become pregnant should not take it. This medicine should not be administered to patients with certain conditions, such as hepatic impairment, severe hypotension, heart valve problems, cardiogenic shock, or unstable heart failure after acute myocardial infarction. Special care is required when using this medicine in patients with primary aldosteronism, hepatic impairment, gastrointestinal disorders, renal artery hypertension, patients on dialysis, the elderly, etc. Taking this medicine may commonly cause side effects such as dizziness or peripheral edema, and serious side effects may occur rarely, so if any abnormal symptoms appear, it is essential to consult a healthcare professional immediately. During pregnancy, this medicine can cause severe side effects such as decreased fetal kidney function, decreased amniotic fluid, and skull formation abnormalities, so it should be discontinued immediately if pregnancy is confirmed. It is recommended that breastfeeding women do not take this medicine, and its safety and efficacy have not been sufficiently established for children under 18 years old, hence it is not recommended for this group. This medicine may interact with other medications, so if you are taking any other drugs, you should consult with a doctor or pharmacist. In case of overdose, hypotension, dizziness, heart problems may occur, and immediate emergency treatment is necessary, with appropriate actions taken based on symptoms. This medicine should be stored out of the reach of children, and the product should be opened and consumed just before use.
Not everyone experiences these, and they can vary from person to person.
This medicine is sensitive to light and should be stored in a light-resistant, sealed container. It is also essential to store it at room temperature between 1 and 30 degrees Celsius to maintain the drug’s effectiveness.
It is a beige and light gray, double-rounded oval tablet.
30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Samsung Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.